Keywords: momenta, files, ind, novel, anticoagulant, m118, pharmaceuticals

Momenta files IND for novel anticoagulant M118

Article | 07 August 2006

Momenta Pharmaceuticals, a US biotechnology firm specializing in the characterization and engineering of complex drugs, says that it has submitted ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in